Rapid review now published in PLOS One

Rapid review now published in PLOS One New research applies behavioural science to identify and understand prescribing choices in neurogenerative diseases – and highlights the need to optimise them A groundbreaking new study, published in PLOS One, has uncovered key behavioural factors influencing how medications are prescribed to people living with neurodegenerative diseases. The findings […]

Alpharmaxim in the press

Person using laptop and phone with glasses in the foreground. Alpharmaxim in the press.

With many organisations beginning to invest in behavioural science, we’ve been shouting in the press about the benefits for pharma companies.

World Alzheimer’s Month 2023

World Alzheimer's Month 2023

In recognition of World Alzheimer’s Month, we created an animation to explore how Alzheimer’s disease affects patients and their families.